Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 43 entries
Sorted by: Best Match Show Resources per page
Advances in neuroimaging to support translational medicine in dementia.

Journal of neurology, neurosurgery, and psychiatry

Cope TE, Weil RS, Düzel E, Dickerson BC, Rowe JB.
PMID: 33568448
J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):263-270. doi: 10.1136/jnnp-2019-322402. Epub 2021 Feb 10.

Advances in neuroimaging are ideally placed to facilitate the translation from progress made in cellular genetics and molecular biology of neurodegeneration into improved diagnosis, prevention and treatment of dementia. New positron emission tomography (PET) ligands allow one to quantify...

Cite
Cope TE, Weil RS, Düzel E, et al. Advances in neuroimaging to support translational medicine in dementia. J Neurol Neurosurg Psychiatry. 2021;92(3):263-270doi: 10.1136/jnnp-2019-322402.
Cope, T. E., Weil, R. S., Düzel, E., Dickerson, B. C., & Rowe, J. B. (2021). Advances in neuroimaging to support translational medicine in dementia. Journal of neurology, neurosurgery, and psychiatry, 92(3), 263-270. https://doi.org/10.1136/jnnp-2019-322402
Cope, Thomas Edmund, et al. "Advances in neuroimaging to support translational medicine in dementia." Journal of neurology, neurosurgery, and psychiatry vol. 92,3 (2021): 263-270. doi: https://doi.org/10.1136/jnnp-2019-322402
Cope TE, Weil RS, Düzel E, Dickerson BC, Rowe JB. Advances in neuroimaging to support translational medicine in dementia. J Neurol Neurosurg Psychiatry. 2021 Mar;92(3):263-270. doi: 10.1136/jnnp-2019-322402. Epub 2021 Feb 10. PMID: 33568448.
Copy Download .nbib Format: NLM
Internalize at your peril: internalizing disorders as risk factors for dementia-cohort study.

GeroScience

Barak Y, Barson D, Davie G, Glue P, Paleacu D.
PMID: 33067707
Geroscience. 2021 Feb;43(1):253-261. doi: 10.1007/s11357-020-00285-y. Epub 2020 Oct 16.

Few studies examined comorbid anxiety and depression's independent association with dementia. We assessed internalizing disorders as risk factors for dementia to avoid pitfalls inherent in separating anxiety and depression. Retrospectively designed prospective comparative cohort study using New Zealand's (NZ)...

Cite
Barak Y, Barson D, Davie G, et al. Internalize at your peril: internalizing disorders as risk factors for dementia-cohort study. Geroscience. 2020;43(1):253-261doi: 10.1007/s11357-020-00285-y.
Barak, Y., Barson, D., Davie, G., Glue, P., & Paleacu, D. (2021). Internalize at your peril: internalizing disorders as risk factors for dementia-cohort study. GeroScience, 43(1), 253-261. https://doi.org/10.1007/s11357-020-00285-y
Barak, Yoram, et al. "Internalize at your peril: internalizing disorders as risk factors for dementia-cohort study." GeroScience vol. 43,1 (2021): 253-261. doi: https://doi.org/10.1007/s11357-020-00285-y
Barak Y, Barson D, Davie G, Glue P, Paleacu D. Internalize at your peril: internalizing disorders as risk factors for dementia-cohort study. Geroscience. 2021 Feb;43(1):253-261. doi: 10.1007/s11357-020-00285-y. Epub 2020 Oct 16. PMID: 33067707; PMCID: PMC8050167.
Copy Download .nbib Format: NLM
Interventions Targeting Reversible Dementia in Down Syndrome.

Journal of the American Geriatrics Society

Callahan BL, Wong C, Ngang PN, Wolf U, Freedman M.
PMID: 27100606
J Am Geriatr Soc. 2016 Apr;64(4):917-9. doi: 10.1111/jgs.14068.

No abstract available.

Cite
Callahan BL, Wong C, Ngang PN, et al. Interventions Targeting Reversible Dementia in Down Syndrome. J Am Geriatr Soc. 2016;64(4):917-9doi: 10.1111/jgs.14068.
Callahan, B. L., Wong, C., Ngang, P. N., Wolf, U., & Freedman, M. (2016). Interventions Targeting Reversible Dementia in Down Syndrome. Journal of the American Geriatrics Society, 64(4), 917-9. https://doi.org/10.1111/jgs.14068
Callahan, Brandy L, et al. "Interventions Targeting Reversible Dementia in Down Syndrome." Journal of the American Geriatrics Society vol. 64,4 (2016): 917-9. doi: https://doi.org/10.1111/jgs.14068
Callahan BL, Wong C, Ngang PN, Wolf U, Freedman M. Interventions Targeting Reversible Dementia in Down Syndrome. J Am Geriatr Soc. 2016 Apr;64(4):917-9. doi: 10.1111/jgs.14068. PMID: 27100606.
Copy Download .nbib Format: NLM
[Dementia].

Neurologija

Orovcanec K.
PMID: 3251153
Neurologija. 1988;37(3):127-41.

No abstract available.

Cite
Orovcanec K. Demencije. [Dementia]. Neurologija. 1988;37(3):127-41
Orovcanec, K. (1988). Demencije. [Dementia]. Neurologija, 37(3), 127-41.
Orovcanec, K. "Demencije." [Dementia]. Neurologija vol. 37,3 (1988): 127-41.
Orovcanec K. Demencije. [Dementia]. Neurologija. 1988;37(3):127-41. Croatian. PMID: 3251153.
Copy Download .nbib Format: NLM
[Clinical study of dementia].

Revista clinica espanola

Portera Sánchez A.
PMID: 3212248
Rev Clin Esp. 1988 Oct;183(5):223-6.

No abstract available.

Cite
Portera Sánchez A. Estudio clínico de las demencias. [Clinical study of dementia]. Rev Clin Esp. 1988;183(5):223-6
Portera Sánchez, A. (1988). Estudio clínico de las demencias. [Clinical study of dementia]. Revista clinica espanola, 183(5), 223-6.
Portera Sánchez, A. "Estudio clínico de las demencias." [Clinical study of dementia]. Revista clinica espanola vol. 183,5 (1988): 223-6.
Portera Sánchez A. Estudio clínico de las demencias. [Clinical study of dementia]. Rev Clin Esp. 1988 Oct;183(5):223-6. Spanish. PMID: 3212248.
Copy Download .nbib Format: NLM
Assessment of dementia flow chart approach to clinical diagnosis.

Neurologia croatica : glasilo Udruzenja neurologa Jugoslavije = official journal of Yugoslav Neurological Association

Mubrin Z, Kos M.
PMID: 1463799
Neurol Croat. 1992;41(3):141-56.

With life spans increasing the number of demented people rises steeply which requires proper diagnosis, particularly in the early stage of the disease. Although the majority of patients suffering from dementia have Alzheimer's disease characterized by slowly progressive course,...

Cite
Mubrin Z, Kos M. Assessment of dementia flow chart approach to clinical diagnosis. Neurol Croat. 1992;41(3):141-56
Mubrin, Z., & Kos, M. (1992). Assessment of dementia flow chart approach to clinical diagnosis. Neurologia croatica : glasilo Udruzenja neurologa Jugoslavije = official journal of Yugoslav Neurological Association, 41(3), 141-56.
Mubrin, Z, and Kos, M. "Assessment of dementia flow chart approach to clinical diagnosis." Neurologia croatica : glasilo Udruzenja neurologa Jugoslavije = official journal of Yugoslav Neurological Association vol. 41,3 (1992): 141-56.
Mubrin Z, Kos M. Assessment of dementia flow chart approach to clinical diagnosis. Neurol Croat. 1992;41(3):141-56. PMID: 1463799.
Copy Download .nbib Format: NLM
Methodological problems of clinical trials in multi-infarct dementia.

Neuroepidemiology

Loeb C, Gandolfo C.
PMID: 2215847
Neuroepidemiology. 1990;9(4):223-7. doi: 10.1159/000110776.

In about 30% of the cases suffering from MID an unequivocal diagnosis can be made only on the basis of histopathological evidence. The imperfect diagnosis has a relevant impact on the methodology to be followed in therapeutic trial. The...

Cite
Loeb C, Gandolfo C. Methodological problems of clinical trials in multi-infarct dementia. Neuroepidemiology. 1990;9(4):223-7doi: 10.1159/000110776.
Loeb, C., & Gandolfo, C. (1990). Methodological problems of clinical trials in multi-infarct dementia. Neuroepidemiology, 9(4), 223-7. https://doi.org/10.1159/000110776
Loeb, C, and Gandolfo, C. "Methodological problems of clinical trials in multi-infarct dementia." Neuroepidemiology vol. 9,4 (1990): 223-7. doi: https://doi.org/10.1159/000110776
Loeb C, Gandolfo C. Methodological problems of clinical trials in multi-infarct dementia. Neuroepidemiology. 1990;9(4):223-7. doi: 10.1159/000110776. PMID: 2215847.
Copy Download .nbib Format: NLM
Etiology, diagnosis, and management of dementias.

Comprehensive therapy

Reyes PF.
PMID: 3060300
Compr Ther. 1988 Jul;14(7):16-21.

No abstract available.

Cite
Reyes PF. Etiology, diagnosis, and management of dementias. Compr Ther. 1988;14(7):16-21
Reyes, P. F. (1988). Etiology, diagnosis, and management of dementias. Comprehensive therapy, 14(7), 16-21.
Reyes, P F. "Etiology, diagnosis, and management of dementias." Comprehensive therapy vol. 14,7 (1988): 16-21.
Reyes PF. Etiology, diagnosis, and management of dementias. Compr Ther. 1988 Jul;14(7):16-21. PMID: 3060300.
Copy Download .nbib Format: NLM
A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence.

Journal of Alzheimer's disease : JAD

Anstey KJ, Ee N, Eramudugolla R, Jagger C, Peters R.
PMID: 31306123
J Alzheimers Dis. 2019;70:S165-S186. doi: 10.3233/JAD-190181.

BACKGROUND: The translation of evidence on dementia risk factors into clinical advice requires careful evaluation of the methodology and scope of data from which risk estimates are obtained.OBJECTIVE: To evaluate the quantity, quality, and representativeness of evidence, we conducted...

Cite
Anstey KJ, Ee N, Eramudugolla R, et al. A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence. J Alzheimers Dis. 2019;70:S165-S186doi: 10.3233/JAD-190181.
Anstey, K. J., Ee, N., Eramudugolla, R., Jagger, C., & Peters, R. (2019). A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence. Journal of Alzheimer's disease : JAD, 70S165-S186. https://doi.org/10.3233/JAD-190181
Anstey, Kaarin J, et al. "A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence." Journal of Alzheimer's disease : JAD vol. 70 (2019): S165-S186. doi: https://doi.org/10.3233/JAD-190181
Anstey KJ, Ee N, Eramudugolla R, Jagger C, Peters R. A Systematic Review of Meta-Analyses that Evaluate Risk Factors for Dementia to Evaluate the Quantity, Quality, and Global Representativeness of Evidence. J Alzheimers Dis. 2019;70:S165-S186. doi: 10.3233/JAD-190181. PMID: 31306123; PMCID: PMC6700718.
Copy Download .nbib Format: NLM
Non-linear associations between sleep duration and the risks of mild cognitive impairment/dementia and cognitive decline: a dose-response meta-analysis of observational studies.

Aging clinical and experimental research

Liang Y, Qu LB, Liu H.
PMID: 30039452
Aging Clin Exp Res. 2019 Mar;31(3):309-320. doi: 10.1007/s40520-018-1005-y. Epub 2018 Jul 23.

BACKGROUND: Mount evidence from observational studies suggested that associations between sleep duration and the risks of mild cognitive impairment (MCI)/dementia or cognitive decline had been recognized.METHODS: To explore the precise and continuous effect of sleep duration on these risks,...

Cite
Liang Y, Qu LB, Liu H. Non-linear associations between sleep duration and the risks of mild cognitive impairment/dementia and cognitive decline: a dose-response meta-analysis of observational studies. Aging Clin Exp Res. 2018;31(3):309-320doi: 10.1007/s40520-018-1005-y.
Liang, Y., Qu, L. B., & Liu, H. (2019). Non-linear associations between sleep duration and the risks of mild cognitive impairment/dementia and cognitive decline: a dose-response meta-analysis of observational studies. Aging clinical and experimental research, 31(3), 309-320. https://doi.org/10.1007/s40520-018-1005-y
Liang, Ying, et al. "Non-linear associations between sleep duration and the risks of mild cognitive impairment/dementia and cognitive decline: a dose-response meta-analysis of observational studies." Aging clinical and experimental research vol. 31,3 (2019): 309-320. doi: https://doi.org/10.1007/s40520-018-1005-y
Liang Y, Qu LB, Liu H. Non-linear associations between sleep duration and the risks of mild cognitive impairment/dementia and cognitive decline: a dose-response meta-analysis of observational studies. Aging Clin Exp Res. 2019 Mar;31(3):309-320. doi: 10.1007/s40520-018-1005-y. Epub 2018 Jul 23. PMID: 30039452.
Copy Download .nbib Format: NLM
Prediction of dementia in people with diabetes.

The lancet. Diabetes & endocrinology

Tolppanen AM.
PMID: 24622354
Lancet Diabetes Endocrinol. 2013 Nov;1(3):164-5. doi: 10.1016/S2213-8587(13)70091-3. Epub 2013 Aug 20.

No abstract available.

Cite
Tolppanen AM. Prediction of dementia in people with diabetes. Lancet Diabetes Endocrinol. 2013;1(3):164-5doi: 10.1016/S2213-8587(13)70091-3.
Tolppanen, A. M. (2013). Prediction of dementia in people with diabetes. The lancet. Diabetes & endocrinology, 1(3), 164-5. https://doi.org/10.1016/S2213-8587(13)70091-3
Tolppanen, Anna-Maija. "Prediction of dementia in people with diabetes." The lancet. Diabetes & endocrinology vol. 1,3 (2013): 164-5. doi: https://doi.org/10.1016/S2213-8587(13)70091-3
Tolppanen AM. Prediction of dementia in people with diabetes. Lancet Diabetes Endocrinol. 2013 Nov;1(3):164-5. doi: 10.1016/S2213-8587(13)70091-3. Epub 2013 Aug 20. PMID: 24622354.
Copy Download .nbib Format: NLM
Cognitive decline in type 2 diabetes.

The lancet. Diabetes & endocrinology

Spauwen PJ, Stehouwer CD.
PMID: 24622745
Lancet Diabetes Endocrinol. 2014 Mar;2(3):188-9. doi: 10.1016/S2213-8587(13)70167-0. Epub 2013 Dec 19.

No abstract available.

Cite
Spauwen PJ, Stehouwer CD. Cognitive decline in type 2 diabetes. Lancet Diabetes Endocrinol. 2013;2(3):188-9doi: 10.1016/S2213-8587(13)70167-0.
Spauwen, P. J., & Stehouwer, C. D. (2014). Cognitive decline in type 2 diabetes. The lancet. Diabetes & endocrinology, 2(3), 188-9. https://doi.org/10.1016/S2213-8587(13)70167-0
Spauwen, Peggy J J, and Stehouwer, Coen D A. "Cognitive decline in type 2 diabetes." The lancet. Diabetes & endocrinology vol. 2,3 (2014): 188-9. doi: https://doi.org/10.1016/S2213-8587(13)70167-0
Spauwen PJ, Stehouwer CD. Cognitive decline in type 2 diabetes. Lancet Diabetes Endocrinol. 2014 Mar;2(3):188-9. doi: 10.1016/S2213-8587(13)70167-0. Epub 2013 Dec 19. PMID: 24622745.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 43 entries